[Pharmacotherapy for weight loss in patients with type 2 diabetes].
Toubro
Søren
S
Københavns Universitet, Det Biovidenskabelige Fakultet for Fødevarer, Veterinaermedicin og Naturressourcer, Institut for Human Ernaering, og Hvidovre Hospital, Ernaeringskonsulenterne Afdeling 225. ST@kvl.dk
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000627:therapeutic use*; D003503:Cyclobutanes / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005473:Fluoxetine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D000077403:Orlistat; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015431:Weight Loss / Q000187:drug effects
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D005473:Fluoxetine; D000077403:Orlistat; C058254:sibutramine